These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24200868)
1. p38α subtype is a potential target to inhibit eNOS activity and NO production in human endothelial cells. Wang B; Xing F; Liu N; Chen D; Li Z; Liu J Microvasc Res; 2014 Jan; 91():58-65. PubMed ID: 24200868 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation. Xing F; Jiang Y; Liu J; Zhao K; Mo Y; Liu Z; Zeng Y Biochem Cell Biol; 2006 Oct; 84(5):780-8. PubMed ID: 17167542 [TBL] [Abstract][Full Text] [Related]
3. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646 [TBL] [Abstract][Full Text] [Related]
4. Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Sun HX; Zeng DY; Li RT; Pang RP; Yang H; Hu YL; Zhang Q; Jiang Y; Huang LY; Tang YB; Yan GJ; Zhou JG Hypertension; 2012 Dec; 60(6):1407-14. PubMed ID: 23108656 [TBL] [Abstract][Full Text] [Related]
5. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Mehta VB; Zhou Y; Radulescu A; Besner GE Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469 [TBL] [Abstract][Full Text] [Related]
7. PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells. Zhang Y; Wang SJ; Han ZH; Li YQ; Xue JH; Gao DF; Wu XS; Wang CX Int J Clin Exp Pathol; 2014; 7(11):8112-7. PubMed ID: 25550859 [TBL] [Abstract][Full Text] [Related]
8. Role of p38 mitogen-activated protein kinase in lipopolysaccharide-induced expression of inducible nitric oxide synthase in human endothelial cells. Kan WH; Yan WS; Jiang Y; Wang JZ; Qin QH; Zhao KS Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):388-92. PubMed ID: 12390692 [TBL] [Abstract][Full Text] [Related]
9. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. Bachetti T; Comini L; Curello S; Bastianon D; Palmieri M; Bresciani G; Callea F; Ferrari R J Mol Cell Cardiol; 2004 Nov; 37(5):939-45. PubMed ID: 15522271 [TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates cyclic strain-induced endothelin-1 expression in human umbilical vein endothelial cells. Hong HJ; Hsu FL; Tsai SC; Lin CH; Liu JC; Chen JJ; Cheng TH; Chan P Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):63-8. PubMed ID: 22032308 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells. Kataoka H; Murakami R; Numaguchi Y; Okumura K; Murohara T Eur J Pharmacol; 2010 Jun; 636(1-3):36-41. PubMed ID: 20353766 [TBL] [Abstract][Full Text] [Related]
13. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway. Li G; Barrett EJ; Barrett MO; Cao W; Liu Z Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. Di Pietro R; Mariggiò MA; Guarnieri S; Sancilio S; Giardinelli A; Di Silvestre S; Consoli A; Zauli G; Pandolfi A J Cell Biochem; 2006 Mar; 97(4):782-94. PubMed ID: 16229016 [TBL] [Abstract][Full Text] [Related]
16. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells. Li Y; Zheng J; Bird IM; Magness RR Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314 [TBL] [Abstract][Full Text] [Related]
17. ET-1 Stimulates Superoxide Production by eNOS Following Exposure of Vascular Endothelial Cells to Endotoxin. Gopalakrishna D; Pennington S; Karaa A; Clemens MG Shock; 2016 Jul; 46(1):60-6. PubMed ID: 26844974 [TBL] [Abstract][Full Text] [Related]
18. Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells. Zhu M; Chen J; Tan Z; Wang J Anesth Analg; 2012 Feb; 114(2):303-9. PubMed ID: 22156331 [TBL] [Abstract][Full Text] [Related]
19. Reduced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelial cells from intrauterine growth restriction pregnancies is not further altered by hypoxia. Casanello P; Krause B; Torres E; Gallardo V; González M; Prieto C; Escudero C; Farías M; Sobrevia L Placenta; 2009 Jul; 30(7):625-33. PubMed ID: 19501907 [TBL] [Abstract][Full Text] [Related]
20. Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling. Chakraborty S; Ain R J Biol Chem; 2017 Apr; 292(16):6600-6620. PubMed ID: 28235804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]